Literature DB >> 35974942

Hydrocephalus associated to posterior fossa tumor-like sarcoidosis: A case report and literature review.

Ghassen Gader1, Chaden Fakhfakh1, Alia Zehani2, Sabeur Thamlaoui3, Ihsèn Zammel1, Mouna Rkhami1, Mohamed Badri1.   

Abstract

Background: Intracranial inflammatory pseudotumors (IIPT) are one of the differential diagnosis for the central nervous system (CNS) tumors. They represent a rare condition that may mimic clinically and radiologically intracranial tumors and induce their complications. Among their etiologies, neurosarcoidosis is one of the less known and less frequent. To the best of our knowledge, only two cases of posterior fossa IIPT have been reported in the literature. We present here the 3rd case related to a neurosarcoidosis. Case presentation: We report the case of a 55-year-old female patient who presented with an altered state of consciousness associated to severe intracranial hypertension syndrome for four months. Glasgow coma scale on admission was 14/15. Brain imaging revealed bilateral cerebellar micronodular meningeal enhancement regarding the mesencephalon and the pons, as well as a nodular lesion of the 4th ventricle causing a triventricular acute hydrocephalus. The patient had a ventriculo-peritoneal shunt with a favorable outcome. Afterwards, she underwent a salivary gland biopsy which confirmed the diagnosis of neurosarcoidosis.
Conclusion: Posterior fossa IIPT are very rare, mainly when located in the posterior fossa, leading to confusion with other pathologies. MRI has an important role in the diagnosis of these lesions, and the determination of their etiology. It shows other than the IIPT itself, many other signs such as leptomeningeal enhancement, nodular lesions or pituitary stalk thickening. These signs can orientate towards the diagnosis. Treatment may associate to symptomatic approach, corticosteroids. Surgical resection may be proposed when the diagnosis remains doubtful.

Entities:  

Keywords:  Inflammatory Pseudotumour; Internal Medicine; Neurosurgery; Sarcoidosis

Year:  2022        PMID: 35974942      PMCID: PMC9348223          DOI: 10.22088/cjim.13.3.646

Source DB:  PubMed          Journal:  Caspian J Intern Med        ISSN: 2008-6164


  18 in total

1.  CSF-ACE activity in probable CNS neurosarcoidosis.

Authors:  Albert J Tahmoush; Mary S Amir; William W Connor; James K Farry; Sevastian Didato; Alice Ulhoa-Cintra; Jennifer M Vasas; Robert J Schwartzman; Harold L Israel; Herbert Patrick
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2002-10       Impact factor: 0.670

Review 2.  Inflammatory pseudotumor: the great mimicker.

Authors:  Madhavi Patnana; Alexander B Sevrukov; Khaled M Elsayes; Chitra Viswanathan; Meghan Lubner; Christine O Menias
Journal:  AJR Am J Roentgenol       Date:  2012-03       Impact factor: 3.959

Review 3.  Etiology of sarcoidosis.

Authors:  Edward S Chen; David R Moller
Journal:  Clin Chest Med       Date:  2008-09       Impact factor: 2.878

Review 4.  Posterior fossa intracranial inflammatory pseudotumor: a case report and literature review.

Authors:  Yu-Jun Lin; Tzu-Ming Yang; Jui-Wei Lin; Ming-Ze Song; Tao-Chen Lee
Journal:  Surg Neurol       Date:  2009-07-15

5.  Epidemiologic patterns of disease expression in sarcoidosis: age, gender and ethnicity-related differences.

Authors:  Pilar Brito-Zerón; Jacobo Sellarés; Xavier Bosch; Fernanda Hernández; Belchin Kostov; Antoni Sisó-Almirall; Carlos Lopez Casany; Josep Manel Santos; Marina Paradela; Marcelo Sánchez; José Ramírez; Antoni Xaubet; Carles Agustí; Manuel Ramos-Casals
Journal:  Clin Exp Rheumatol       Date:  2016-04-06       Impact factor: 4.473

6.  Long-term follow-up of neurosarcoidosis.

Authors:  D Ferriby; J de Seze; T Stojkovic; E Hachulla; B Wallaert; A Destée; P Y Hatron; P Vermersch
Journal:  Neurology       Date:  2001-09-11       Impact factor: 9.910

7.  Epidemiology of Sarcoidosis 1946-2013: A Population-Based Study.

Authors:  Patompong Ungprasert; Eva M Carmona; James P Utz; Jay H Ryu; Cynthia S Crowson; Eric L Matteson
Journal:  Mayo Clin Proc       Date:  2015-12-22       Impact factor: 7.616

8.  Central nervous system sarcoidosis: follow-up at MR imaging during steroid therapy.

Authors:  J L Dumas; D Valeyre; C Chapelon-Abric; C Belin; J C Piette; H Tandjaoui-Lambiotte; M Brauner; D Goldlust
Journal:  Radiology       Date:  2000-02       Impact factor: 11.105

9.  Epidemiology of sarcoidosis in Japan.

Authors:  T Morimoto; A Azuma; S Abe; J Usuki; S Kudoh; K Sugisaki; M Oritsu; T Nukiwa
Journal:  Eur Respir J       Date:  2007-10-24       Impact factor: 16.671

Review 10.  Neurosarcoidosis: a clinical dilemma.

Authors:  Elske Hoitsma; Carin G Faber; Marjolein Drent; Om P Sharma
Journal:  Lancet Neurol       Date:  2004-07       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.